Priser
Platform
Blog
Om os
Download
National Medical Care
National Medical Care
SAUDI STOCK EXCHANGE
0

Om

The National Medical Care Company operates within the healthcare sector, providing a variety of medical services and solutions in Saudi Arabia. Its primary function is to manage and operate healthcare facilities, offering comprehensive medical care to patients. The company's scope extends across general medical services, allied health services, and specialized healthcare services, catering to a broad spectrum of patient needs with a focus on quality and efficiency. As a significant player in the Middle Eastern healthcare landscape, National Medical Care Company contributes to the region’s healthcare system by ensuring the availability of advanced medical technology and skilled healthcare professionals. Its operations include the management of hospitals, clinics, and medical centers, positioning it as a key participant in the ongoing development of healthcare infrastructure in the Kingdom. The company's commitment to enhancing healthcare services supports its vital role in meeting the healthcare demands of a growing population.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NATIONAL MEDICAL CARE MED ENDAVU: Køb National Medical Care ($4005) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i National Medical Care, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker4005
Land
Saudi-Arabien
Hjemmesidecare.med.sa
SektorSundhed
IndustriMedicinske plejefaciliteter

Udbytter

2SAR
'20
1SAR
'21
1SAR
'22
1SAR
'23
2SAR
'24
2SAR
'25
Ex-udbytte-dato20. maj 2025
Udbytteafkast1,71%